Significant Options Trading on Tuesday: VST, ARE, MBI
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 28 2025
0mins
Source: NASDAQ.COM
Alexandria Real Estate Equities Inc (ARE) Options Activity: ARE options have seen a volume of 9,419 contracts today, representing about 941,900 underlying shares, which is 53.3% of its average daily trading volume of 1.8 million shares. Notably, the $65 strike call option expiring on April 17, 2026, has had 733 contracts traded.
MBIA Inc. (MBI) Options Activity: MBI options have recorded a volume of 1,352 contracts today, equating to approximately 135,200 underlying shares, or 52.1% of its average daily trading volume of 259,670 shares. The $9 strike call option expiring on November 21, 2025, has seen significant activity with 1,312 contracts traded.
Options Trading Insights: The article provides insights into the trading history of both ARE and MBI options, highlighting the specific strike prices that have garnered high trading volumes.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ARE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ARE
Wall Street analysts forecast ARE stock price to rise
15 Analyst Rating
3 Buy
12 Hold
0 Sell
Hold
Current: 49.210
Low
41.00
Averages
56.85
High
67.00
Current: 49.210
Low
41.00
Averages
56.85
High
67.00
About ARE
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Alexandria Real Estate Ranks 16th in Talent Readiness Among S&P 500 Companies
- Talent Readiness Ranking: Alexandria Real Estate Equities has been recognized as 16th in talent readiness on The Wall Street Journal's inaugural 'Best Companies for the Future' list, marking it as the highest-ranked equity REIT among all S&P 500 companies, showcasing its exceptional ability to attract and retain top talent.
- Cultural Advantage: The company fosters a people-first culture that combines personal humility with professional will, committed to changing the world through innovation, which not only enhances employee engagement but also promotes leadership development, laying a solid foundation for long-term success.
- Leadership Stability: Alexandria's executive team averages 15 years of tenure, and this strong retention rate supports business continuity while reflecting the company's stability and depth of expertise in the industry, further enhancing its competitive position in the market.
- Investment in Talent Development: The company has made substantial investments in leadership development, employee engagement, and wellness, offering a comprehensive benefits package that includes 100% company-paid medical premiums and the unique Alexandria Lifeline™ program, aimed at meeting the needs of employees and their families, thereby increasing job satisfaction and loyalty.
See More
Alexandria Real Estate Ranks 16th in Talent Readiness Among S&P 500
- Talent Readiness Ranking: Alexandria Real Estate Equities ranked 16th in talent readiness on The Wall Street Journal's inaugural 'Best Companies for the Future' list, being the highest among all S&P 500 companies, showcasing its exceptional ability to attract and retain top talent.
- Cultural Advantage: The company fosters a people-first culture that emphasizes leadership development and employee engagement, committed to creating a workplace that promotes employee growth and success, thereby enhancing its competitive position in the market.
- Investment in Development: Alexandria has made substantial investments in employee development and leadership training, ensuring that its management team averages 15 years of experience with the company, which not only supports business continuity but also strengthens leadership stability.
- Innovative Health Benefits: The company offers a comprehensive benefits package, including a top-tier medical plan with 100% company-paid premiums and the unique Alexandria Lifeline™ program, providing specialized medical care for employees facing serious illnesses, further enhancing employee satisfaction and loyalty.
See More
Morgan Stanley Downgrades Life Sciences REITs Amid Market Uncertainty
- Rating Downgrade: Morgan Stanley downgraded Healthpeak Properties (DOC) from Overweight to Equal-weight, although the price target was raised from $20 to $22, indicating confidence in its strong senior housing, yet limited visibility on overall market recovery may hinder future growth.
- Market Pressure: Alexandria Real Estate Equities (ARE) was downgraded to Underweight, with analysts noting that despite some constructive leasing data, the Q1 performance still showed near-term pressure, reflecting uncertainty in market demand.
- Stock Price Reaction: During pre-market trading on Friday, DOC's stock fell 1.02% to $20.29, while ARE's stock decreased by 0.17% to $52.68, indicating market sensitivity to the rating changes.
- Future Outlook: Morgan Stanley stated that Healthpeak Properties' outlook would improve if lab market trends exceed the 3% to 4% estimates, while ARE needs tenant demand to convert into signed leases to stabilize occupancy and enhance same-store net operating income.
See More
Investment Opportunities After Dividend Cuts
- Dividend Cut Impact: Morgan Stanley highlights that while dividend cuts may lead to short-term stock price declines, stocks often rebound after initial reactions, particularly when companies improve their financial positions.
- Healthcare Realty Trust Performance: This real estate investment trust cut its dividend by 23% over the past year, yet its stock has risen 20% in 2026, with a current dividend yield of 4.7%, indicating management's execution is exceeding expectations.
- Dow Inc. Adjustment: After halving its dividend to 35 cents per share last July, Dow's stock has surged 42% in 2026, maintaining a 4.2% dividend yield, with the CEO stating this adjustment provides greater financial flexibility for high-return opportunities.
- Market Analyst Trends: Morgan Stanley's report reveals that despite dividend cuts from companies like LyondellBasell and DuPont, analysts remain optimistic about Dow, with nine analysts rating it as a buy or strong buy.
See More
Alexandria Real Estate Launches Life Science Ecosystem Initiative
- Pioneering Industry Role: Alexandria Real Estate has played a pioneering role in New York City's life science cluster for over 25 years, transforming the market from an academic focus to a commercial ecosystem through its unique Megacampus™ concept, significantly enhancing regional innovation capabilities.
- Significant Investment Returns: Alexandria Venture Investments achieved a successful exit with Petra Pharmaceuticals in 2020, which was acquired by Eli Lilly, marking a substantial return on investment and further solidifying its core position in the innovation economy.
- Showcasing Success Stories: Intra-Cellular Therapies, supported by Alexandria Center, progressed from early investment to a $14.6 billion acquisition by Johnson & Johnson in 2025, demonstrating exceptional achievements in neuroscience research and validating the long-term value of sustained investment.
- Market Capitalization: As of March 31, 2026, Alexandria Real Estate's market capitalization reached $20.44 billion, with an asset base of 35.8 million square feet of operating properties, showcasing its leadership and robust asset foundation in the life science real estate sector.
See More
Alexandria Real Estate Fuels Life Science Innovation
- Pioneering Industry Role: Alexandria Real Estate has played a pioneering role in New York City's life science cluster for over 25 years, transforming the market from an academic focus to a commercial life science innovation hub, significantly enhancing regional innovation capacity and investment appeal.
- Significant Investment Returns: Alexandria Venture Investments achieved a successful exit with Petra Pharmaceuticals being acquired by Eli Lilly in 2020, with the undisclosed amount indicating substantial returns, further solidifying its leadership position in the life sciences sector.
- Showcasing Success Stories: Intra-Cellular Therapies, supported by Alexandria, evolved from an initial investment 24 years ago to a $14.6 billion acquisition by Johnson & Johnson in 2025, demonstrating the company's long-term commitment and strategic value in driving success in the biopharmaceutical field, validating its investment model.
- Market Capitalization Scale: As of March 31, 2026, Alexandria Real Estate's market capitalization reached $20.44 billion, with an asset base of 35.8 million square feet of operating properties, showcasing its robust strength and ongoing growth potential in the life science real estate sector.
See More
Alexandria Real Estate Ranks 16th in Talent Readiness Among S&P 500 Companies
- Talent Readiness Ranking: Alexandria Real Estate Equities has been recognized as 16th in talent readiness on The Wall Street Journal's inaugural 'Best Companies for the Future' list, marking it as the highest-ranked equity REIT among all S&P 500 companies, showcasing its exceptional ability to attract and retain top talent.
- Cultural Advantage: The company fosters a people-first culture that combines personal humility with professional will, committed to changing the world through innovation, which not only enhances employee engagement but also promotes leadership development, laying a solid foundation for long-term success.
- Leadership Stability: Alexandria's executive team averages 15 years of tenure, and this strong retention rate supports business continuity while reflecting the company's stability and depth of expertise in the industry, further enhancing its competitive position in the market.
- Investment in Talent Development: The company has made substantial investments in leadership development, employee engagement, and wellness, offering a comprehensive benefits package that includes 100% company-paid medical premiums and the unique Alexandria Lifeline™ program, aimed at meeting the needs of employees and their families, thereby increasing job satisfaction and loyalty.
See More
Alexandria Real Estate Ranks 16th in Talent Readiness Among S&P 500
- Talent Readiness Ranking: Alexandria Real Estate Equities ranked 16th in talent readiness on The Wall Street Journal's inaugural 'Best Companies for the Future' list, being the highest among all S&P 500 companies, showcasing its exceptional ability to attract and retain top talent.
- Cultural Advantage: The company fosters a people-first culture that emphasizes leadership development and employee engagement, committed to creating a workplace that promotes employee growth and success, thereby enhancing its competitive position in the market.
- Investment in Development: Alexandria has made substantial investments in employee development and leadership training, ensuring that its management team averages 15 years of experience with the company, which not only supports business continuity but also strengthens leadership stability.
- Innovative Health Benefits: The company offers a comprehensive benefits package, including a top-tier medical plan with 100% company-paid premiums and the unique Alexandria Lifeline™ program, providing specialized medical care for employees facing serious illnesses, further enhancing employee satisfaction and loyalty.
See More
Morgan Stanley Downgrades Life Sciences REITs Amid Market Uncertainty
- Rating Downgrade: Morgan Stanley downgraded Healthpeak Properties (DOC) from Overweight to Equal-weight, although the price target was raised from $20 to $22, indicating confidence in its strong senior housing, yet limited visibility on overall market recovery may hinder future growth.
- Market Pressure: Alexandria Real Estate Equities (ARE) was downgraded to Underweight, with analysts noting that despite some constructive leasing data, the Q1 performance still showed near-term pressure, reflecting uncertainty in market demand.
- Stock Price Reaction: During pre-market trading on Friday, DOC's stock fell 1.02% to $20.29, while ARE's stock decreased by 0.17% to $52.68, indicating market sensitivity to the rating changes.
- Future Outlook: Morgan Stanley stated that Healthpeak Properties' outlook would improve if lab market trends exceed the 3% to 4% estimates, while ARE needs tenant demand to convert into signed leases to stabilize occupancy and enhance same-store net operating income.
See More
Investment Opportunities After Dividend Cuts
- Dividend Cut Impact: Morgan Stanley highlights that while dividend cuts may lead to short-term stock price declines, stocks often rebound after initial reactions, particularly when companies improve their financial positions.
- Healthcare Realty Trust Performance: This real estate investment trust cut its dividend by 23% over the past year, yet its stock has risen 20% in 2026, with a current dividend yield of 4.7%, indicating management's execution is exceeding expectations.
- Dow Inc. Adjustment: After halving its dividend to 35 cents per share last July, Dow's stock has surged 42% in 2026, maintaining a 4.2% dividend yield, with the CEO stating this adjustment provides greater financial flexibility for high-return opportunities.
- Market Analyst Trends: Morgan Stanley's report reveals that despite dividend cuts from companies like LyondellBasell and DuPont, analysts remain optimistic about Dow, with nine analysts rating it as a buy or strong buy.
See More
Alexandria Real Estate Launches Life Science Ecosystem Initiative
- Pioneering Industry Role: Alexandria Real Estate has played a pioneering role in New York City's life science cluster for over 25 years, transforming the market from an academic focus to a commercial ecosystem through its unique Megacampus™ concept, significantly enhancing regional innovation capabilities.
- Significant Investment Returns: Alexandria Venture Investments achieved a successful exit with Petra Pharmaceuticals in 2020, which was acquired by Eli Lilly, marking a substantial return on investment and further solidifying its core position in the innovation economy.
- Showcasing Success Stories: Intra-Cellular Therapies, supported by Alexandria Center, progressed from early investment to a $14.6 billion acquisition by Johnson & Johnson in 2025, demonstrating exceptional achievements in neuroscience research and validating the long-term value of sustained investment.
- Market Capitalization: As of March 31, 2026, Alexandria Real Estate's market capitalization reached $20.44 billion, with an asset base of 35.8 million square feet of operating properties, showcasing its leadership and robust asset foundation in the life science real estate sector.
See More
Alexandria Real Estate Fuels Life Science Innovation
- Pioneering Industry Role: Alexandria Real Estate has played a pioneering role in New York City's life science cluster for over 25 years, transforming the market from an academic focus to a commercial life science innovation hub, significantly enhancing regional innovation capacity and investment appeal.
- Significant Investment Returns: Alexandria Venture Investments achieved a successful exit with Petra Pharmaceuticals being acquired by Eli Lilly in 2020, with the undisclosed amount indicating substantial returns, further solidifying its leadership position in the life sciences sector.
- Showcasing Success Stories: Intra-Cellular Therapies, supported by Alexandria, evolved from an initial investment 24 years ago to a $14.6 billion acquisition by Johnson & Johnson in 2025, demonstrating the company's long-term commitment and strategic value in driving success in the biopharmaceutical field, validating its investment model.
- Market Capitalization Scale: As of March 31, 2026, Alexandria Real Estate's market capitalization reached $20.44 billion, with an asset base of 35.8 million square feet of operating properties, showcasing its robust strength and ongoing growth potential in the life science real estate sector.
See More
